Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zymeworks Inc
(NQ:
ZYME
)
11.72
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
11.72
Bid (Size)
9.800 (2)
Ask (Size)
11.90 (1)
Prev. Close
11.72
Today's Range
11.72 - 11.72
52wk Range
6.015 - 13.14
Shares Outstanding
57,771,204
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Zymeworks Announces Participation in Upcoming Investor Conferences
August 22, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Share Repurchase Program of up to $60 Million of its Common Stock
August 01, 2024
Zymeworks intends to commence the Share Repurchase Program with $30.0 million in initial repurchases anticipated to begin promptly and continue during the second half of 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Performance
YTD
+12.91%
+12.91%
1 Month
+12.48%
+12.48%
3 Month
+39.03%
+39.03%
6 Month
-2.41%
-2.41%
1 Year
+59.46%
+59.46%
More News
Read More
Zymeworks Provides Corporate Update and Reports Second Quarter 2024 Financial Results
August 01, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Navigating 6 Analyst Ratings For Zymeworks
June 06, 2024
Via
Benzinga
Zymeworks Announces Participation in Upcoming Investor Conferences
July 30, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer
July 25, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate
July 22, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024
July 11, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers
June 17, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Week In Review: Osaka Enters $445 Million Deal For Two Hearing Loss Candidates From France's Cilcare
June 15, 2024
Via
Talk Markets
Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer
June 10, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.